NCT05907954 2026-03-16
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
IDEAYA Biosciences
Phase 2 Active not recruiting
IDEAYA Biosciences
Leiden University Medical Center
Eli Lilly and Company
Nobelpharma
Pfizer
Nobelpharma